FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for TFBS Bioscience's FCF Yield % or its related term are showing as below:
ROCO:6939'
s FCF Yield % Range Over the Past 10 Years
Min: -48.35 Med: -1.49 Max: 1.97
Current: -32.44
During the past 6 years, the highest FCF Yield % of TFBS Bioscience was 1.97%. The lowest was -48.35%. And the median was -1.49%.
ROCO:6939's FCF Yield % is ranked worse than 86.45% of 214
companies
in the Medical Diagnostics & Research industry
Industry Median: -1.345
vs ROCO:6939: -32.44
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
TFBS Bioscience FCF Yield % Related Terms
TFBS Bioscience FCF Yield % Historical Data
* Premium members only.
The historical data trend for TFBS Bioscience's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6939 vs TMO, DHR, IDXX: FCF Yield % Comparison
For the Diagnostics & Research subindustry, TFBS Bioscience's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TFBS Bioscience FCF Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's FCF Yield % distribution charts can be found below:
* The bar in red indicates where TFBS Bioscience's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TFBS Bioscience (ROCO:6939) has a FCF Yield % of -32.44 as of Jul. 08, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on TFBS Bioscience and its competitors. According to the industry distribution chart, TFBS Bioscience ranks #185 out of 214 companies in the Medical Diagnostics & Research industry, placing it in the top 86.4%.
Is TFBS Bioscience's FCF Yield % too high?
TFBS Bioscience's current FCF Yield % is -32.44. Based on the distribution chart, TFBS Bioscience ranks #185 out of 214 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's FCF Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, TFBS Bioscience ranks #185 out of 214 companies for FCF Yield %. This places TFBS Bioscience in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Diagnostics & Research company?
A good FCF Yield % depends on the Medical Diagnostics & Research industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on TFBS Bioscience and its competitors. TFBS Bioscience's current FCF Yield % is -32.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.17, compared to a current price of NT$20.60 — trading 36% below its estimated fair value. The current FCF Yield % is -32.44. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current FCF Yield % is -32.44 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?
Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued.
The current stock price of NT$20.60 is trading 36% below its estimated GF Value™ of NT$32.17.
GuruFocus considers TFBS Bioscience to be Possible Value Trap.
Key valuation signals for ROCO:6939:
FCF Yield %: -32.44
GF Value™: NT$32.17 vs. price of NT$20.60 (36% below fair value)
No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score
Get the complete analysis for ROCO:6939
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6939 has been successfully added to your 
